This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Law Office Of Brodsky & Smith, LLC Announces Investigation Of Accretive Healthcare, Inc.

BALA CYNWYD, Pa., May 6, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential shareholder claims against Accretive Healthcare, Inc. ("Accretive" or the "Company") (NYSE: AH) in connection with possible violations of federal securities laws.

At all relevant times Accretive reported strong financial and operational results to investors. However, on February 26, 2013 the Company announced that it would postpone the release of its financial results because it was evaluating the timing of revenue recognition. On this news, shares of Accretive stock fell $2.54 per share, to close on February 27, 2013 at $9.57 per share. Then on March 8, 2013 the Company disclosed that the timing of revenue recognition under certain managed service contracts was incorrect. As a result, Accretive announced that it would restate its financial statements for the years 2010, 2011, and parts of 2012. The investigation concerns possible breaches of fiduciary duty and other violations of both federal and state law.

If you purchased shares of Accretive between May 20, 2010 and February 26, 2013 and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, visiting http://brodsky-smith.com/581-ah-accretive-healthcare-inc.html, by e-mail at investorrelations@brodsky-smith.com, by calling toll free 877-LEGAL-90.

Attorney advertising. Prior results do not guarantee a similar outcome.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,686.69 -59.29 -0.33%
S&P 500 2,104.43 -4.20 -0.20%
NASDAQ 5,129.2280 +0.4430 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs